Italia - italiano - Ministero della Salute

bayer ag - iodosulfuron metil sodio; amidosulfuron; mefenpyr etere; mesosulfuron-metile; - granuli idrodispersibili - 1.0 g; 5.0 g; 9.0 g; 3.0 g i valori indicati sono per 100 g di prodotto. - mesosulfuron-methyl; 3%; iodosulfuron-methyl; sodium; 1%; amidosulfuron; 5% - diserbante

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

tentan ag - methylis salicylas, dextrocamphora, levomentholum, methylis nicotinas, thymolum, terebinthinae aetheroleum medicinale, menthae piperitae aetheroleum, eucalipti, aetheroleum, myristicae fragrantis aetheroleum - lozione - methylis salicylas 100 mg, dextrocamphora 20 mg, levomentholum 10 mg, methylis nicotinas 10 mg, thymolum 3.4 mg, terebinthinae aetheroleum medicinale 7.5 mg, menthae piperitae aetheroleum 3.4 mg, eucalipti, aetheroleum 3,3 mg, myristicae fragrantis aetheroleum 2.5 mg, grassi e alcoli nostro nuovo con, propylenglycolum, conserv.: propylis parahydroxybenzoas, e 218, excipiens annuncio emulsionem per 1 g. - kutanes reumatismi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 54 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Unione Europea - italiano - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Unione Europea - italiano - EMA (European Medicines Agency)

teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).